Authors:
LIGTENBERG G
OEY PL
KLEIN I
WIENEKE G
KOOMANS HA
BLANKESTIJN PJ
Citation: G. Ligtenberg et al., DIRECT EVIDENCE FOR SUPPRESSION OF SYMPATHETIC ACTIVITY IN CHRONIC-RENAL-FAILURE BY ENALAPRIL, Journal of hypertension, 16, 1998, pp. 2342-2342
Authors:
BLANKESTIJN PJ
LIGTENBERG G
DIJKHORST LT
OEY PL
WIENEKE G
KOOMANS HA
Citation: Pj. Blankestijn et al., DIRECT EVIDENCE FOR RESETTING OF BARORECEPTOR MEDIATED SYMPATHETIC ACTIVITY BY ENALAPRIL IN CHRONIC-RENAL-FAILURE, Kidney international, 52(2), 1997, pp. 560-560
Authors:
BLANKESTIJN PJ
LIGTENBERG G
DIJKHORST LT
OEY PL
WIENEKE G
KOOMANS HA
Citation: Pj. Blankestijn et al., DIRECT EVIDENCE FOR SUPPRESSION OF SYMPATHETIC ACTIVITY IN CHRONIC-RENAL-FAILURE BY ENALAPRIL, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1482-1482
Citation: G. Wieneke et al., VARIANCE OF CENTRAL TIMING OF VOICED AND VOICELESS PERIODS AMONG STUTTERERS AND NONSTUTTERERS, Journal of fluency disorders, 20(2), 1995, pp. 171-189
Authors:
HASSAN SM
JENNEKENS FGI
WIENEKE G
VELDMAN H
Citation: Sm. Hassan et al., CALCITONIN-GENE-RELATED PEPTIDE-LIKE IMMUNOREACTIVITY, IN BOTULINUM TOXIN-PARALYZED RAT MUSCLES, Neuromuscular disorders, 4(5-6), 1994, pp. 489-496
Authors:
HASSAN SM
JENNEKENS FGI
WIENEKE G
VELDMAN H
Citation: Sm. Hassan et al., ELIMINATION OF SUPERFLUOUS NEUROMUSCULAR-JUNCTIONS IN RAT CALF MUSCLES RECOVERING FROM BOTULINUM TOXIN-INDUCED PARALYSIS, Muscle & nerve, 17(6), 1994, pp. 623-631